PapersFlow Research Brief
Ginger and Zingiberaceae research
Research Guide
What is Ginger and Zingiberaceae research?
Ginger and Zingiberaceae research is the scientific study of the phytochemical, pharmacological, and toxicological properties of ginger (Zingiber officinale Roscoe) and related plants in the Zingiberaceae family, focusing on bioactive compounds and their biological activities such as antioxidant, anti-inflammatory, and anticancer effects.
This field encompasses 30,926 published works examining ginger's bioactive compounds including phenolic compounds, terpenes, and polysaccharides. Research demonstrates ginger's antioxidant, anti-inflammatory, anticancer, and antidiabetic activities through in vitro and in vivo studies. Key investigations also cover toxicological profiles and interactions enhancing bioavailability of related Zingiberaceae compounds like curcumin.
Topic Hierarchy
Research Sub-Topics
Antioxidant Properties of Ginger Extracts
This sub-topic investigates the free radical scavenging activity of ginger bioactive compounds like gingerols and shogaols in cellular models. Researchers study mechanisms involving Nrf2 pathway activation and protection against oxidative stress-related diseases.
Anti-inflammatory Effects of Ginger
Examines ginger's inhibition of pro-inflammatory cytokines, COX-2, and NF-κB pathways in models of arthritis, colitis, and metabolic inflammation. Studies explore dose-response relationships and synergy with conventional drugs.
Ginger Bioactive Compounds in Cancer Prevention
Focuses on gingerols, paradols, and shogaols inducing apoptosis, cell cycle arrest, and metastasis inhibition in cancer cell lines and xenografts. Researchers analyze structure-activity relationships and signaling pathways like PI3K/Akt.
Ginger in Diabetes Management
This area evaluates ginger's effects on glycemic control, insulin sensitivity, and β-cell protection in diabetic animal models and human trials. Investigations include modulation of PPARγ and AMPK pathways.
Toxicological Profile of Ginger
Assesses safety, genotoxicity, and subchronic toxicity of ginger extracts across doses in rodents and humans, identifying no-observed-adverse-effect levels. Studies address interactions with pharmaceuticals and heavy metal contamination risks.
Why It Matters
Ginger and Zingiberaceae research supports applications in diabetes management, cancer prevention, and inflammation control due to bioactive compounds like gingerols and shogaols. Ali et al. (2007) in "Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): A review of recent research" reviewed ginger's antidiabetic effects, including blood glucose reduction in animal models. Mao et al. (2019) in "Bioactive Compounds and Bioactivities of Ginger (Zingiber officinale Roscoe)" identified 31 ginger phenolics with antioxidant activity measured by DPPH and ABTS assays, aiding pharmaceutical development. Shoba et al. (1998) showed piperine from Piperaceae, related to Zingiberaceae studies, increased curcumin bioavailability by 2000% in humans, informing drug formulation in healthcare.
Reading Guide
Where to Start
"Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): A review of recent research" by Ali et al. (2007) provides a foundational overview of ginger's properties with 1547 citations, ideal for beginners to grasp core phytochemical, pharmacological, and toxicological aspects before primary studies.
Key Papers Explained
Ali et al. (2007) in "Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): A review of recent research" synthesizes ginger-specific properties, building on Ammon and Wahl (1991) in "Pharmacology of Curcuma longa" which establishes anti-inflammatory mechanisms in Zingiberaceae. Mao et al. (2019) in "Bioactive Compounds and Bioactivities of Ginger (Zingiber officinale Roscoe)" extends this by cataloging 31 phenolics and their activities, while Shoba et al. (1998) in "Influence of Piperine on the Pharmacokinetics of Curcumin in Animals and Human Volunteers" connects bioavailability enhancements relevant to ginger compounds.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Studies remain focused on ginger's core bioactivities without recent preprints or news in the last 12 months. Current frontiers involve detailing compound-specific mechanisms from Mao et al. (2019) and toxicological limits from Ali et al. (2007), with no new data on clinical translations.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Cellular defenses against damage from reactive oxygen species | 1994 | Physiological Reviews | 2.4K | ✕ |
| 2 | Influence of Piperine on the Pharmacokinetics of Curcumin in A... | 1998 | Planta Medica | 1.9K | ✕ |
| 3 | Pharmacology of<i>Curcuma longa</i> | 1991 | Planta Medica | 1.7K | ✕ |
| 4 | Some phytochemical, pharmacological and toxicological properti... | 2007 | Food and Chemical Toxi... | 1.5K | ✕ |
| 5 | Claudin-based tight junctions are crucial for the mammalian ep... | 2002 | The Journal of Cell Bi... | 1.5K | ✓ |
| 6 | Bioactive Compounds and Bioactivities of Ginger (Zingiber offi... | 2019 | Foods | 1.3K | ✓ |
| 7 | A Review on Antibacterial, Antiviral, and Antifungal Activity ... | 2014 | BioMed Research Intern... | 1.2K | ✓ |
| 8 | Acetaminophen-induced Hepatic Necrosis | 1974 | Pharmacology | 1.1K | ✕ |
| 9 | Safety and Anti-Inflammatory Activity of Curcumin: A Component... | 2003 | The Journal of Alterna... | 1.1K | ✕ |
| 10 | Influence of two plant extracts on broilers performance, diges... | 2004 | Poultry Science | 969 | ✓ |
Frequently Asked Questions
What are the main bioactive compounds in ginger?
Ginger contains phenolic compounds such as gingerols and shogaols, terpenes, polysaccharides, lipids, organic acids, and raw fibers. Mao et al. (2019) in "Bioactive Compounds and Bioactivities of Ginger (Zingiber officinale Roscoe)" attribute health benefits primarily to these phenolics. These compounds contribute to antioxidant and anti-inflammatory effects observed in pharmacological studies.
How does ginger exhibit anti-inflammatory activity?
Ginger extracts show anti-inflammatory effects in animal models after parenteral application. Ammon and Wahl (1991) in "Pharmacology of Curcuma longa" indicate curcumin and volatile oils from related Zingiberaceae are responsible. Ali et al. (2007) confirm similar mechanisms for ginger in "Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): A review of recent research".
What pharmacological effects of ginger are supported by research?
Ginger demonstrates antioxidant, anti-inflammatory, anticancer, and antidiabetic effects. Mao et al. (2019) detail these bioactivities linked to phenolic compounds in "Bioactive Compounds and Bioactivities of Ginger (Zingiber officinale Roscoe)". Ali et al. (2007) review evidence for these properties alongside toxicological data.
How does piperine affect Zingiberaceae compound bioavailability?
Piperine inhibits hepatic and intestinal glucuronidation, enhancing curcumin absorption from Curcuma longa. Shoba et al. (1998) in "Influence of Piperine on the Pharmacokinetics of Curcumin in Animals and Human Volunteers" report a 2000% increase in bioavailability in humans. This informs ginger-related bioavailability studies.
What is the current state of ginger toxicology research?
Research covers toxicological properties alongside pharmacology. Ali et al. (2007) in "Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): A review of recent research" summarizes recent findings on safety. No recent preprints or news indicate shifts in toxicological assessments.
Open Research Questions
- ? What specific mechanisms underlie ginger's anticancer effects in human clinical trials?
- ? How do ginger bioactive compounds interact with drug metabolism pathways to affect pharmacokinetics?
- ? What are the long-term toxicological thresholds for ginger consumption in diabetic patients?
- ? Which ginger compounds most effectively cross the blood-brain barrier for neuroprotective applications?
- ? How do environmental factors influence the yield and bioactivity of ginger phytochemicals?
Recent Trends
The field maintains 30,926 works with no specified 5-year growth rate.
Citation leaders like Ali et al. with 1547 citations and Mao et al. (2019) with 1274 citations reflect sustained interest in ginger bioactivities.
2007No recent preprints or news coverage in the last 12 months indicate stable research without new shifts.
Research Ginger and Zingiberaceae research with AI
PapersFlow provides specialized AI tools for Pharmacology, Toxicology and Pharmaceutics researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
AI Academic Writing
Write research papers with AI assistance and LaTeX support
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Ginger and Zingiberaceae research with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Pharmacology, Toxicology and Pharmaceutics researchers